TuHURA BIOSCIENCES, INC./NV Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, shares, new issues for the quarter ending 2019-12-31 was 1.38K shares.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, shares, new issues for the quarter ending 2019-09-30 was 1.28K shares.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, shares, new issues for the quarter ending 2014-03-31 was 250.00K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2019-12-31 | 1.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | |
| 2019-09-30 | 1.28K shares 10-Q · filed 2019-11-13 | |
| 2014-03-31 | 250.00K shares 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |